Background: The serum potassium (K +) level is kept in a narrow range to sustain normal physiology within the human body by the kidneys. The serum K + level in different stages of chronic kidney disease (CKD) remains undefined. Methods: We conducted a cross-sectional study to observe the serum K + level in patients without clinical manifestations of hyperkalemia in the late stages of CKD (stages 3-5). A total of 531 patients with late stage CKD were included and followed up for at least 1 year, from March 2006 to May 2007. The patients were sub-grouped by stages of CKD, which were determined by a "Modification of Diet in Renal Disease" equation estimating the glomerular filtration rate (eGFR). The serum creatinine, eGFR and K + levels were recorded at least twice during the study. We analyzed the average K + level in these late-stage CKD patients. Results: The average K + level increased along with renal function deterioration in the late stages of CKD (stage 3: 4.36 ± 0.49; stage 4: 4.50 ± 0.55; stage 5: 4.69 ± 0.73 mEq/L, p < 0.05). Men and patients with diabetes mellitus, a low eGFR, and a low hemoglobin might have higher levels of serum K +. We also noticed that there was a linear increase in the standard deviation of the serum K + level as renal function deteriorated. The use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was not associated with hyperkalemia in our patients. Conclusion: Our results reflected that the serum K + level increased in correlation with the decline in the eGFR in the late stages of CKD. Also, male gender, diabetes mellitus, and anemia might be risk factors for higher K + levels in CKD patients. The variation in the serum K + level became wider as renal failure progressed.
|頁（從 - 到）||418-425|
|期刊||Chang Gung Medical Journal|
|出版狀態||已發佈 - 2011|
ASJC Scopus subject areas
- 醫藥 (全部)